Gene · 9133
Papers2,908
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,908
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Doxorubicin downregulates cell cycle regulatory hub genes in breast cancer cells. | Med Oncol | 2024 | 39115587 | PubTator, text mining | PubMed |
| Investigation of the relationship between COVID-19 and pancreatic cancer using bioinformatics and systems biology approaches. | Medicine (Baltimore) | 2024 | 39093763 | PubTator, text mining | PubMed |
| Identification of Hub Genes for Psoriasis and Cancer by Bioinformatic Analysis. | Biomed Res Int | 2024 | 39045407 | PubTator, text mining | PubMed |
| Integrative analysis of gene and microRNA expression profiles reveals candidate biomarkers and regulatory networks in psoriasis. | Medicine (Baltimore) | 2024 | 39028999 | PubTator, text mining | PubMed |
| Identification of most representative hub-genes for diagnosis, prognosis, and therapies of hepatocellular carcinoma. | Chin Clin Oncol | 2024 | 38984486 | PubTator, text mining | PubMed |
| Origin recognition complex 6 overexpression promotes growth of glioma cells. | Cell Death Dis | 2024 | 38971772 | PubTator, text mining | PubMed |
| Identification of hub genes and pathways in hepatitis B virus-associated hepatocellular carcinoma: A comprehensive in silico study. | Health Sci Rep | 2024 | 38895552 | PubTator, text mining | PubMed |
| Deciphering the miRNA-mRNA Interaction Landscape between Breast Cancer and Triple-Negative Breast Cancer: An Integrated Bioinformatics Approach. | ACS Omega | 2024 | 38882157 | PubTator, text mining | PubMed |
| Hypermethylation and low expression of FOXM1 predisposes women to unexplained recurrent miscarriage by impairing trophoblast stem cell proliferation. | Cell Signal | 2024 | 38871040 | PubTator, text mining | PubMed |
| High expression of CCNB2 is an independent predictive poor prognostic biomarker and correlates with immune infiltrates in breast carcinoma. | Heliyon | 2024 | 38831807 | PubTator, text mining | PubMed |
| Proteo-genomic characterization of cirrhosis-associated liver cancers reveals potential subtypes and therapeutic targets. | Clin Transl Oncol | 2024 | 38806996 | PubTator, text mining | PubMed |
| Irbesartan ameliorates diabetic kidney injury in db/db mice by restoring circadian rhythm and cell cycle. | J Transl Int Med | 2024 | 38799791 | PubTator, text mining | PubMed |
| Identification and analysis of prognostic immune cell homeostasis characteristics in lung adenocarcinoma. | Clin Respir J | 2024 | 38757752 | PubTator, text mining | PubMed |
| Target prediction and potential application of dihydroartemisinin on hepatocarcinoma treatment. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | 38713259 | PubTator, text mining | PubMed |
| Cellular and Transcriptional Response of Human Astrocytes to Hybrid Protein Materials. | ACS Appl Bio Mater | 2024 | 38632900 | PubTator, text mining | PubMed |
| Identification of hub genes and diagnostic efficacy for triple-negative breast cancer through WGCNA and Mendelian randomization. | Discov Oncol | 2024 | 38609711 | PubTator, text mining | PubMed |
| Theabrownin as a Potential Prebiotic Compound Regulates Lipid Metabolism via the Gut Microbiota, Microbiota-Derived Metabolites, and Hepatic FoxO/PPAR Signaling Pathways. | J Agric Food Chem | 2024 | 38567990 | PubTator, text mining | PubMed |
| DELVE: feature selection for preserving biological trajectories in single-cell data. | Nat Commun | 2024 | 38553455 | PubTator, text mining | PubMed |
| Oleuropein Supplementation Ameliorates Long-Course Diabetic Nephropathy and Diabetic Cardiomyopathy Induced by Advanced Stage of Type 2 Diabetes in db/db Mice. | Nutrients | 2024 | 38542759 | PubTator, text mining | PubMed |
| Differential gene expression analysis pipelines and bioinformatic tools for the identification of specific biomarkers: A review. | Comput Struct Biotechnol J | 2024 | 38510977 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9133/papers?page=7